シングルユースバイオプロセシングの世界市場：2023-2030年

世界のシングルユースバイオプロセシング市場は、予測期間（2023-2030年）にCAGR 10.9％で成長すると予測されています。シングルユースバイオプロセシング技術は、ろ過、混合、精製、上流発現、貯蔵、分離など、幅広いバイオ医薬品用途で使用されています。シングルユースバイオリアクターの採用が進んでいることと先端技術が相まって、この市場の世界の成長を支えています。シングルユースバイオリアクターの利点は、製造業者に柔軟性を与えることです。ダウンタイムの主な原因の一つは、上流工程でバイオリアクターを準備することです。シングルユースバイオリアクターは、後続バッチのためのバイオリアクターの準備に費やす時間を大幅に削減します。したがって、市場プレーヤーは、市場成長をさらに強化する大型シングルユースバイオリアクター・バイオプロセシング・ソリューションの導入にも注力しています。例えば、2021年2月、オープンアクセス生物製剤技術プラットフォームを有する世界的企業であるWuXi Biologics社は、中国のMFG5原薬（DS）製造施設が、9つの4,000Lシングルユースバイオリアクターを配備し、36,000Lの生産能力を持つGMP稼働に成功したと発表しました。

セグメント別の展望

世界のシングルユースバイオプロセシング市場では、培地バッグと容器が大きなシェアを占めると予想されます。

製品の中で、メディアバッグと容器のサブセグメントが世界のシングルユースバイオプロセシング市場でかなりのシェアを占めると予想されています。シングルユースバイオプロセシング技術は、従来のステンレス製システムと比較して、洗浄やバリデーションにかかる時間の短縮、柔軟性の向上、交差汚染のリスクの低減など、いくつかの利点があります。保護、充填・排出、凍結・解凍、保存、原薬出荷などの重要なプロセス工程における様々なシングルユース容器やアセンブリの挙動に関する様々な企業の広範な専門知識が、シングルユースバッグに反映されています。例えば、2022年10月、Single Use Support GmbH社は、IRISというブランド名で、新しいシングルユースバイオプロセス容器で製品ポートフォリオを拡大しています。同社はバイオ医薬品の流体管理分野で信頼性の高いプロセスソリューションを提供し、ベンダーにとらわれないアプローチを追求し続けています。

地域別展望

世界のシングルユースバイオプロセシング市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、遺伝子ベースの治療薬の急成長を背景に、ウイルスベクターや遺伝子治療の生産にシングルユース技術を採用する機運が高まっていることから、世界市場で突出したシェアを占めると予想されています。主な市場プレイヤーには、Foxx Life Sciences Pvt. Ltd., Cesco Bioengineering Co.Ltd.、PharmNXT Biotechなどです。

北米地域はシングルユースバイオプロセシングの世界市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、シングルユースバイオプロセシング機器に対する需要の増加に起因しています。また、同地域では、疾病予防対策を支援するためにワクチン生産への注目が高まっていることも、同市場の成長を後押ししています。シングルユースバイオプロセシング技術の採用は、交差汚染のリスク低減、切り替えプロセスの合理化、ターンアラウンドタイムの短縮など、シングルユースバイオプロセシング技術が提供する魅力的なメリットによって推進されています。さらに、ポリマー材料の進歩により、ステンレス製リアクターと同等の細胞培養性能を提供するシングルユースバイオリアクターが開発され、市場の拡大に拍車をかけています。さらに、シングルユース技術の採用を促進することを目的としたBPSA（Bio-process System Alliance）が北米に存在することで、同地域における使い捨てシステムの売上がさらに促進されると予想されます。

さらに、CMOにおけるディスポーザブルの導入動向と相まって、北米に拠点を展開しようとする受託サービスプロバイダーの関心が高まっていることも、地元企業だけでなく世界の企業による継続的な投資の触媒として機能しています。主な市場プレイヤーは、Agilitech Group、Avantor, Inc.、Corning Inc.、Entegris, Inc.、Pall Corp.、Thermo Fisher Scientific Inc.などです。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Eppendorf AG
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Merck KGaA
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Thermo Fisher Scientific Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• シングルユースバイオプロセシングの世界市場：製品別
  • ろ過アセンブリ
  • メディアバッグと容器
  • 使い捨てバイオリアクター
  • 使い捨てミキサー
  • その他（使い捨てフィルターカートリッジ）
• シングルユースバイオプロセシングの世界市場：用途別
  • ろ過
  • 細胞培養
  • 精製
  • その他（ミキシング）
• シングルユースバイオプロセシングの世界市場：エンドユーザー別
  • バイオ医薬品メーカー
  • 学術・臨床研究機関
  • その他（CRO、CMO）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• AGC Biologics
• Agilitech Group
• Avantor, Inc.
• Cesco Bioengineering Co. Ltd.
• Cytiva LifeSciencel
• Entegris, Inc.
• Foxx Life Sciences Pvt. Ltd.
• Getinge, Merck & Co. Inc.
• Kuhner AG
• Lonza Group
• Meissner Filtration Products, Inc.
• Pall Corp.
• PBS Biotech, Inc.
• PharmNXT Biotech
• Rentschler Biopharma SE
• Saint-Gobain Life Sciences
• Sentinel Process Systems

LIST OF TABLES

• 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 2. GLOBAL SINGLE-USE FILTRATION ASSEMBLIES BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL SINGLE-USE MEDIA BAGS AND CONTAINERS BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 4. GLOBAL SINGLE-USE DISPOSABLE BIOREACTOR BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 5. GLOBAL SINGLE-USE DISPOSABLE MIXERS BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 6. GLOBAL OTHER SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 8. GLOBAL SINGLE-USE BIOPROCESSING FILTRATION MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 9. GLOBAL SINGLE-USE BIOPROCESSING CELL CULTURE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 10. GLOBAL SINGLE-USE BIOPROCESSING PURIFICATION MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 11. GLOBAL SINGLE-USE BIOPROCESSING OTHER MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
• 13. GLOBAL SINGLE-USE BIOPROCESSING PRODUCTS FOR BIOPHARMACEUTICAL MANUFACTURERS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 14. GLOBAL SINGLE-USE BIOPROCESSING PRODUCTS FOR ACADEMIC AND CLINICAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 15. GLOBAL SINGLE-USE BIOPROCESSING PRODUCT FOR OTHERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 18. NORTH AMERICAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 19. NORTH AMERICAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 20. NORTH AMERICAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
• 21. EUROPEAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 22. EUROPEAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 23. EUROPEAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 24. EUROPEAN SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
• 25. ASIA- PACIFIC SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 26. ASIA- PACIFIC SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 27. ASIA- PACIFIC SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 28. ASIA- PACIFIC SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
• 29. REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 31. REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 32. REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHAREBY PRODUCT, 2022 VS 2030 (%)
• 2. GLOBAL SINGLE-USE FILTRATION ASSEMBLIES BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 3. GLOBAL SINGLE-USE MEDIA BAGS AND CONTAINERS BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 4. GLOBAL SINGLE-USE DISPOSABLE BIOREACTOR BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 5. GLOBAL SINGLE-USE DISPOSABLE MIXERS BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 6. GLOBAL OTHER SINGLE-USE BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHAREBY APPLICATION, 2022 VS 2030 (%)
• 8. GLOBAL SINGLE-USE BIOPROCESSING FILTRATION MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 9. GLOBAL SINGLE-USE BIOPROCESSING CELL CULTURE MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 10. GLOBAL SINGLE-USE BIOPROCESSING PURIFICATION MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 11. GLOBAL SINGLE-USE BIOPROCESSING OTHER MARKET SHAREBY REGION, 2022 VS 2030 (%)
• 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHAREBY END USERS, 2022 VS 2030 (%)
• 13. GLOBAL SINGLE-USE BIOPROCESSING PRODUCTS FOR BIOPHARMACEUTICAL MANUFACTURERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL SINGLE-USE BIOPROCESSING PRODUCTS FOR ACADEMIC AND CLINICAL RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL SINGLE-USE BIOPROCESSING PRODUCT FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 18. US SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 19. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 20. UK SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 21. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 22. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 23. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 24. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 25. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 26. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 27. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 28. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 29. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 30. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 31. REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Single-Use Bioprocessing Market Size, Share & Trends Analysis Report by Product (Filtration Assemblies, Media Bags and Containers, Disposable Bioreactors, Disposable Mixers and Other), by Application (Filtration, Cell Culture, Purification and Other), and by End Users (Biopharmaceutical Manufacturers, Academic and Clinical Research Institutes and Other),Forecast Period (2023-2030).

The global single-use bioprocessing market is anticipated to grow at a CAGR of 10.9% during the Forecast Period (2023-2030). Single-use bioprocessing technology is used in a broad range of biopharmaceutical applications, including filtration, mixing, purification, upstream expression, storage, and separation. The growing adoption of single use bioreactor coupled with advance technology is the key factor supporting the growth of the market globally. The advantage of single-use bioreactors is the flexibility they allow manufacturers. One of the main culprits in downtime is preparing the bioreactor in the upstream process. Single-use bioreactors drastically decrease the time spent preparing the bioreactor for the subsequent batch. Hence, the market players are also focusing on introducing large single-use bioreactors bioprocessing solutions that further bolster the market growth. For instance, in February 2021, WuXi Biologics a global company with open-access biologics technology platforms, announced that its MFG5 Drug Substance (DS) manufacturing facility in China has successfully launched GMP operation, with a capacity of 36,000L, deploying nine 4,000L single-use bioreactors.

Segmental Outlook

The global single-use bioprocessing market is segmented on the product, application, and end users. Based on the product, the market is sub-segmented into filtration assemblies, media bags and containers, disposable bioreactors, disposable mixers and others (disposable filter cartridges). Based on the application, the market is sub-segmented into filtration, cell culture, purification and other (mixing). Further, on the basis of end users, the market is sub-segmented into biopharmaceutical manufacturers, academic and clinical research institutes and others (CROs, CMOs). Among the applications, the filtration sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of advanced Single-use filtration systems are comprised of a number of fully disposable components, including the entire fluid pathway and filters. This allows for easy and quick adaptation to changing requirements - be it the need for different filter pore sizes or an increased or decreased filling volume.

The Media Bags and Containers Sub-Segment is Anticipated to Hold a Considerable Share of the Global Single-Use Bioprocessing Market

Among the products, the media bags and containers sub-segment is expected to hold a considerable share of the global single-use bioprocessing market. The segmental growth is attributed to the growing uses of single-use bioprocessing technologies that offer several advantages over traditional stainless-steel systems, including reduced cleaning and validation time, increased flexibility, and reduced risk of cross-contamination. Various companies' extensive expertise in the behavior of different single-use containers and assemblies in critical process steps, such as protection, filling & draining, freezing & thawing, storage and shipping of drug substances, that translated into single-use bags. For instance, in October 2022, Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The company provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Regional Outlook

The global single-use bioprocessing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the adoption of single-use technologies for viral vector and gene therapy production is gaining momentum, driven by the rapid growth of gene-based therapeutics. The key market players include Foxx Life Sciences Pvt. Ltd., Cesco Bioengineering Co. Ltd., PharmNXT Biotech and others

The North America Region is Expected to Grow at a Significant CAGR in the Global Single-Use Bioprocessing Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to an increase in demand for single-use bioprocessing equipment is also driven by an increasing focus on vaccine production to aid in disease prevention measures in the region. single-use bioprocessing technologies for various biopharmaceutical applications have propelled the growth of the market. The adoption of single-use bioprocessing technologies is propelled by the compelling benefits they offer, including reduced risk of cross-contamination, streamlined changeover processes, and faster turnaround times. Additionally, advancements in polymer materials have led to the development of single-use bioreactors that offer cell culture performance at par with stainless steel reactors, further fueling market expansion. Moreover, the presence of the Bio-process System Alliance (BPSA) in North America, that aims at advancing the adoption of single-use technologies, is expected to further drive the sales of disposable systems in the region.

Furthermore, the increasing interest of contract service providers to develop their base in North America, coupled with the trend of implementation of disposables in CMOs, acts as a catalyst for continued investments by local as well as global companies. The key market players include Agilitech Group, Avantor, Inc., Corning Inc., Entegris, Inc., Pall Corp., Thermo Fisher Scientific Inc. and others

Market Players Outlook

The major companies serving the single-use bioprocessing market include: Corning Inc., Eppendorf AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2020, 3i Group plc launched a single-use bioprocessing platform serving the biopharmaceutical sector with the acquisitions of Cellon, Silicone Altimex and TBL Performance Plastics. The company offer industry products, such as the PharmaTainerTM bottles and carboy product line, aSURE® fittings, Tri-Clamp® ends, Bio-EaseTM clamps, and a wide range of tubing solutions.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global single-use bioprocessing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Eppendorf AG
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Merck KGaA
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Thermo Fisher Scientific Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Single-Use Bioprocessing Market by Product
  • 4.1.1. Filtration Assemblies
  • 4.1.2. Media Bags and Containers
  • 4.1.3. Disposable Bioreactors
  • 4.1.4. Disposable Mixers
  • 4.1.5. Other(Disposable Filter Cartridges)
• 4.2. Global Single-Use Bioprocessing Market by Application
  • 4.2.1. Filtration
  • 4.2.2. Cell Culture
  • 4.2.3. Purification
  • 4.2.4. Other(Mixing)
• 4.3. Global Single-Use Bioprocessing Market by End-Users
  • 4.3.1. Biopharmaceutical Manufacturers
  • 4.3.2. Academic and Clinical Research Institutes
  • 4.3.3. Other (CROs, CMOs)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. AGC Biologics
• 6.2. Agilitech Group
• 6.3. Avantor, Inc.
• 6.4. Cesco Bioengineering Co. Ltd.
• 6.5. Cytiva LifeSciencel
• 6.6. Entegris, Inc.
• 6.7. Foxx Life Sciences Pvt. Ltd.
• 6.8. Getinge, Merck & Co. Inc.
• 6.9. Kuhner AG
• 6.10. Lonza Group
• 6.11. Meissner Filtration Products, Inc.
• 6.12. Pall Corp.
• 6.13. PBS Biotech, Inc.
• 6.14. PharmNXT Biotech
• 6.15. Rentschler Biopharma SE
• 6.16. Saint-Gobain Life Sciences
• 6.17. Sentinel Process Systems